The Latest Breaking News from JP Morgan

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

SVB Leerink is initiating coverage of HilleVax Inc (NASDAQ:HLVX) shares with an Outperform rating and a $30 price target.  The analyst believes the company’s potentially first-in-class infant norovirus vaccine HIL214 represents a uniquely de-risked opportunity.  It estimates $625 million in risk-adjusted infant HIL214 sales in 2030E ($1 billion unadjusted).  The outlook is supported by…

LX Group collaborated with the Carlyle Group private equity fund manager to propose a takeover offer for Magnachip Semiconductor Corp (NYSE:MX), a media reported. LX Group recently submitted a letter of intent to acquire Magnachip Semiconductor to JP Morgan in the United States.  The industry valued Magnachip at $1.2 billion (1.5 trillion won).  Also Read: Magnachip…

Integrated LatAm healthcare and pharmaceutical company Procaps Group (NASDAQ:PROC) has agreed to acquire Grupo Somar (including Grupo Farmacéutico Somar, Química y Farmacia, Gelcaps, and related entities) from Advent International, private equity. Deal terms were not disclosed. Grupo Somar is focused on developing, manufacturing, and marketing branded generic, private label, and OTC products targeted to…